Stanley Hoy
Pulmonary Disease · Austin, TXNPI 1043660228
Payments from drug & device makers
Across 104 payments — averaging $435.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$42K
- Pinnacle Biologics, Inc$2K
- United Therapeutics Corporation$206
- Abiomed$145
- Pulmonx Corporation$141
- Siemens Medical Solutions USA, Inc.$138
- plus $1K from 22 others
What the payments were for
- Speaking & faculty fees$3,0007%
- Travel & lodging$4,1509%
- Food & beverage$3,4758%
- Education$34,66877%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 50 | $41,615 |
| Pinnacle Biologics, Inc | 8 | $1,794 |
| United Therapeutics Corporation | 5 | $206 |
| Abiomed | 1 | $145 |
| Pulmonx Corporation | 2 | $141 |
| Siemens Medical Solutions USA, Inc. | 1 | $138 |
| Galvanize Therapeutics, Inc | 1 | $137 |
| Boehringer Ingelheim | 5 | $134 |
| GSK | 5 | $127 |
| Acelrx Pharmaceuticals, Inc. | 1 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $100 |
| Medtronic | 1 | $92 |
| AstraZeneca | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Merck | 2 | $60 |
| Viatris Specialty LLC | 1 | $59 |
| Ambu Inc. | 1 | $56 |
| Insmed, Inc. | 2 | $55 |
| ANI Pharmaceuticals, Inc. | 1 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Amgen | 1 | $23 |
| Grifols USA, LLC | 1 | $21 |
| Olympus America Inc. | 1 | $19 |
| Sanofi | 1 | $17 |
| Philips North America LLC | 1 | $14 |
| ERBE USA Inc | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$41,160
- Photofrin$1,537
- Impella$145
- ALIYA SYSTEM$137
- ORENITRAM$125
- CHARTIS CATHETER$117
- ZEPHYR DELIVERY CATHETER$117
- ZEPHYR ENDOBRONCHIAL VALVE$117
- PULMONX CHARTIS TABLET CONSOLE$117
- DSUVIA$101
- RELISTOR$100
How this compares
$45,293 in reported general payments places this provider in the 85th percentile of 904 pulmonary disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Varenicline Tartrate | 14 | $1,721 |
| Fluticasone Propionate | 11 | $188 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Austin
- Mehdi MirsaeidiAustin$1.8M
- Raju ReddyAustin$344K
- Charles AndrewsSan Antonio$17M
- Ivan RosasHouston$13.8M
- Shahrukh KureishyMcKinney$12.4M
- Raksha JainDallas$3.4M
- Kelly ChinDallas$2.7M
- Julie PhilleyTyler$2.4M
- Nicola HananiaHouston$2.2M
- Sandeep SahayHouston$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.